Lundbeck
HLUN-B.CO
#2732
Rank
A$9.14 B
Marketcap
A$9.22
Share price
-0.33%
Change (1 day)
14.13%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

P/S ratio for Lundbeck (HLUN-B.CO)

P/S ratio as of July 2026 (TTM): 1.59

According to Lundbeck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.60. At the end of 2026 the company had a P/S ratio of 1.48.

P/S ratio history for Lundbeck from 2010 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.48-12.32%
20251.68-3.95%
20241.757.88%
20231.6315.89%
20221.40420.15%
20210.2697-19.79%
20200.3362-13.9%
20190.3905-5.33%
20180.4125-18.79%
20170.50798.7%
20160.467310.18%
20150.424189.73%
20140.2235-9.1%
20130.245964.69%
20120.1493-35.81%
20110.232622.92%
20100.1892